59
Participants
Start Date
December 18, 2024
Primary Completion Date
May 29, 2025
Study Completion Date
May 29, 2025
Efsubaglutide Alfa Injection
Efsubaglutide Alfa 3mg/0.5ml
Efsubaglutide Alfa Injection
Efsubaglutide Alfa 1mg/0.5ml
Nanjing First Hospital, Nanjing
CangZhou Hospital of Integrated TCM and Western Medicine in Hebei Province, Cangzhou
Huzhou Central Hospital, Huzhou
Jiangsu Province Offical Hospital, Nanjing
Ningbo First Hospital, Ningbo
Ningbo Medical Center Lihuili Hospital, Ningbo
The First Affiliated Hospital of Soochow University, Suzhou
The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou
Wenzhou Central Hospital, Wenzhou
Zibo Municipal Hospital, Zibo
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
OTHER